Research ArticleIMMUNE DEVELOPMENT

The checkpoint for agonist selection precedes conventional selection in human thymus

+ See all authors and affiliations

Science Immunology  24 Feb 2017:
Vol. 2, Issue 8, eaah4232
DOI: 10.1126/sciimmunol.aah4232

You are currently viewing the abstract.

View Full Text

Surviving selection

T cells walk a tight rope in fighting infection without harming the body—They respond to foreign antigens in the context of self-MHC without reacting so strongly that they attack self. Conventional T cells achieve this balance through positive and negative selection in the thymus. Verstichel et al. report that agonist-selected T cells in humans undergo a different process. A PD-1 T cell population acquired features of tissue-resident effector cells and an innate functional effector phenotype in response to self-antigen in the thymus. Immature thymocytes were diverted to this agonist selection pathway before conventional selection. This timing suggests that, rather than being by-products of failed negative selection, these cells instead follow a distinct path to survive thymic selection.

Abstract

The thymus plays a central role in self-tolerance, partly by eliminating precursors with a T cell receptor (TCR) that binds strongly to self-antigens. However, the generation of self-agonist–selected lineages also relies on strong TCR signaling. How thymocytes discriminate between these opposite outcomes remains elusive. Here, we identified a human agonist–selected PD-1+ CD8αα+ subset of mature CD8αβ+ T cells that displays an effector phenotype associated with agonist selection. TCR stimulation of immature post–β-selection thymocyte blasts specifically gives rise to this innate subset and fixes early T cell receptor alpha variable (TRAV) and T cell receptor alpha joining (TRAJ) rearrangements in the TCR repertoire. These findings suggest that the checkpoint for agonist selection precedes conventional selection in the human thymus.

View Full Text

Related Content